In Silico Optimization of Atrial Fibrillation-Selective Sodium Channel Blocker Pharmacodynamics
- 1 March 2012
- journal article
- Published by Elsevier in Biophysical Journal
- Vol. 102 (5) , 951-960
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Fondation Leducq (07-CVD-03)
- Canadian Institutes of Health Research (6957, MOP 44365)
This publication has 35 references indexed in Scilit:
- Mechanisms of atrial-selective block of Na+channels by ranolazine: II. Insights from a mathematical modelAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Mechanisms of atrial-selective block of Na+ channels by ranolazine: I. Experimental analysis of the use-dependent blockAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- A Computational Model to Predict the Effects of Class I Anti-Arrhythmic Drugs on Ventricular RhythmsScience Translational Medicine, 2011
- Exploring the role of pH in modulating the effects of lidocaine in virtual ischemic tissueAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical PracticeDrugs, 2010
- New Pharmacological Strategies for the Treatment of Atrial FibrillationAnnals of Noninvasive Electrocardiology, 2009
- Novel Approaches for Pharmacological Management of Atrial FibrillationDrugs, 2009
- Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlatesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Atrial‐Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationAnnals of the New York Academy of Sciences, 2008
- Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationCirculation, 2007